Search

Search Constraints

You searched for: Author/Creator Harter, P

Search Results

1. 18 Efficacy of maintenance olaparib plus bevacizumab by biomarker status in clinical higher- and lower-risk patients with newly diagnosed, advanced ovarian cancer in the PAOLA-1 trial. (13th November 2020)

2. 27 Therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer. (13th November 2020)

3. 439 Primary symptoms in women with different histopathological subtypes of gynaecological sarcoma – results of a prospective intergroup registry for gynaecological sarcoma (REGSA – NOGGO RU1). (13th November 2020)

4. 934OAlienor/ENGOT-ov7 randomized trial exploring weekly paclitaxel (wP) + bevacizumab (bev) vs wP alone for patients with ovarian sex cord tumors (SCT) in relapse. (23rd October 2018)

5. C.07 Predicting individualized risk of recurrence: development and validation of a DNA-methylation based nomogram in meningioma. (5th June 2019)

6. C.07 Predicting individualized risk of recurrence: development and validation of a DNA-methylation based nomogram in meningioma. (June 2019)

8. Dilution of molecular-pathologic gene signatures (MPG) by parameter unrelated to tumor biology (UTB) may prevent prediction of the resection status after debulking surgery in patients with advanced ovarian cancer. (1st November 2019)

9. EP1168 The influence of obesity on tumor recurrence in vulvar cancer patients. (1st November 2019)